{"id":"https://openalex.org/W2129184868","doi":"https://doi.org/10.1016/s1474-4422(12)70018-2","title":"Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial","display_name":"Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial","publication_year":2012,"publication_date":"2012-02-28","ids":{"openalex":"https://openalex.org/W2129184868","doi":"https://doi.org/10.1016/s1474-4422(12)70018-2","mag":"2129184868","pmid":"https://pubmed.ncbi.nlm.nih.gov/22377180"},"language":"en","primary_location":{"id":"doi:10.1016/s1474-4422(12)70018-2","doi":"https://doi.org/10.1016/s1474-4422(12)70018-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1474-4422(12)70018-2","pdf_url":"http://www.thelancet.com/article/S1474442212700182/pdf","source":{"id":"https://openalex.org/S70053155","display_name":"The Lancet Neurology","issn_l":"1474-4422","issn":["1474-4422","1474-4465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thelancet.com/article/S1474442212700182/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014921958","display_name":"Laura Jayne Bonnett","orcid":"https://orcid.org/0000-0002-6981-9212","observed_orcids":["https://orcid.org/0000-0002-6981-9212"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Bonnett","raw_affiliation_strings":["Department of Biostatistics, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046267575","display_name":"Catrin Tudur Smith","orcid":"https://orcid.org/0000-0003-3051-1445","observed_orcids":["https://orcid.org/0000-0003-3051-1445"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catrin Tudur Smith","raw_affiliation_strings":["Department of Biostatistics, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079303751","display_name":"David F. Smith","orcid":"https://orcid.org/0000-0002-0048-4012","observed_orcids":["https://orcid.org/0000-0002-0048-4012"]},"institutions":[{"id":"https://openalex.org/I2802833755","display_name":"Walton Centre","ror":"https://ror.org/05cvxat96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802833755"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Smith","raw_affiliation_strings":["The Walton Centre Foundation NHS Trust, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Walton Centre Foundation NHS Trust, Liverpool, UK","institution_ids":["https://openalex.org/I2802833755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072801492","display_name":"Paula Ruth Williamson","orcid":"https://orcid.org/0000-0001-9802-6636","observed_orcids":["https://orcid.org/0000-0001-9802-6636"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula Williamson","raw_affiliation_strings":["Department of Biostatistics, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048642442","display_name":"David William Chadwick","orcid":"https://orcid.org/0000-0003-3145-055X","observed_orcids":["https://orcid.org/0000-0003-3145-055X"]},"institutions":[{"id":"https://openalex.org/I2802833755","display_name":"Walton Centre","ror":"https://ror.org/05cvxat96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802833755"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Chadwick","raw_affiliation_strings":["The Walton Centre Foundation NHS Trust, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Walton Centre Foundation NHS Trust, Liverpool, UK","institution_ids":["https://openalex.org/I2802833755"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005069325","display_name":"Anthony Guy Marson","orcid":"https://orcid.org/0000-0002-6861-8806","observed_orcids":["https://orcid.org/0000-0002-6861-8806"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Anthony G Marson","raw_affiliation_strings":["Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK","Department of Molecular & Clinical Pharmacology; University of Liverpool; Liverpool UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Department of Molecular & Clinical Pharmacology; University of Liverpool; Liverpool UK","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005069325"],"corresponding_institution_ids":["https://openalex.org/I146655781"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":{"value":7280,"currency":"USD","value_usd":7280},"fwci":3.3893,"has_fulltext":true,"cited_by_count":71,"citation_normalized_percentile":{"value":0.9241915,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"4","first_page":"331","last_page":"340"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/focal-epilepsy","display_name":"focal epilepsy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.8399999737739563},{"id":"https://openalex.org/keywords/seizure-remission","display_name":"seizure remission","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8730000257492065},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.8960000276565552},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.7860000133514404},{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":0.9779999852180481},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/seizure-control","display_name":"seizure control","score":0.5690000057220459},{"id":"https://openalex.org/keywords/seizure-types","display_name":"seizure types","score":0.48500001430511475},{"id":"https://openalex.org/keywords/temporal-lobe-epilepsy","display_name":"temporal lobe epilepsy","score":0.7390000224113464},{"id":"https://openalex.org/keywords/seizure-frequency","display_name":"seizure frequency","score":0.4259999990463257},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.5289999842643738},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.503000020980835},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.8692327737808228},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.7166415452957153},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.6593723893165588},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5276673436164856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.513727068901062},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41118013858795166},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.304385244846344},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.21134385466575623},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.13439002633094788}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078330","descriptor_name":"Oxcarbazepine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s1474-4422(12)70018-2","doi":"https://doi.org/10.1016/s1474-4422(12)70018-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1474-4422(12)70018-2","pdf_url":"http://www.thelancet.com/article/S1474442212700182/pdf","source":{"id":"https://openalex.org/S70053155","display_name":"The Lancet Neurology","issn_l":"1474-4422","issn":["1474-4422","1474-4465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Neurology","raw_type":"journal-article"},{"id":"pmid:22377180","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22377180","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Neurology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1016/s1474-4422(12)70018-2","doi":"https://doi.org/10.1016/s1474-4422(12)70018-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1474-4422(12)70018-2","pdf_url":"http://www.thelancet.com/article/S1474442212700182/pdf","source":{"id":"https://openalex.org/S70053155","display_name":"The Lancet Neurology","issn_l":"1474-4422","issn":["1474-4422","1474-4465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3173865631","display_name":"Defining priorities and communicating evidence about benefit and harm of interventions for people with epilepsy: Putting evidence into practice","funder_award_id":"RP-PG-0606-1062","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129184868.pdf","grobid_xml":"https://content.openalex.org/works/W2129184868.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W350025413","https://openalex.org/W1865423802","https://openalex.org/W1969532917","https://openalex.org/W1973948212","https://openalex.org/W1977247044","https://openalex.org/W1989537794","https://openalex.org/W1994572997","https://openalex.org/W2000062521","https://openalex.org/W2011911182","https://openalex.org/W2027515217","https://openalex.org/W2056735380","https://openalex.org/W2063600541","https://openalex.org/W2073140442","https://openalex.org/W2076993158","https://openalex.org/W2085495803","https://openalex.org/W2099478180","https://openalex.org/W2103365094","https://openalex.org/W2105087430","https://openalex.org/W2108606586","https://openalex.org/W2114953502","https://openalex.org/W2117995225","https://openalex.org/W2129925362","https://openalex.org/W2134365734","https://openalex.org/W2138521331","https://openalex.org/W2139992285","https://openalex.org/W2147974822","https://openalex.org/W2160571019","https://openalex.org/W2166610199","https://openalex.org/W2325173251","https://openalex.org/W2494169975","https://openalex.org/W3175417087","https://openalex.org/W4299537215","https://openalex.org/W4299689471"],"related_works":["https://openalex.org/W2005079421","https://openalex.org/W1994825668","https://openalex.org/W2339822617","https://openalex.org/W2126323398","https://openalex.org/W2899158534","https://openalex.org/W2776109173","https://openalex.org/W2138521331","https://openalex.org/W1979742136","https://openalex.org/W2067569181","https://openalex.org/W2775271971"],"abstract_inverted_index":{"BACKGROUND:":[0],"Epilepsy":[1],"is":[2],"a":[3,14,58,284,362,369],"heterogeneous":[4],"disorder,":[5],"with":[6,22,69,90],"outcomes":[7],"ranging":[8],"from":[9,39,129,307,368],"immediate":[10],"remission":[11,128,273],"after":[12],"taking":[13],"first":[15,308],"antiepileptic":[16,65,187,286,377],"drug":[17,287],"to":[18,36,43,97,108,124,140,163,218,269,339],"frequent":[19],"unremitting":[20],"seizures":[21,215,220,334],"multiple":[23],"treatment":[24,109,149,164,183,195,259,281,289,348],"failures.":[25],"Few":[26],"prognostic":[27,366],"models":[28,382],"enable":[29],"prediction":[30],"of":[31,85,113,119,127,148,154,158,214,249,272,333,365,395],"outcome;":[32],"we":[33,135,166],"therefore":[34],"aimed":[35],"use":[37],"data":[38],"the":[40,81,146,152,391],"SANAD":[41,55],"study":[42,56,134],"predict":[44],"outcome":[45],"overall":[46],"and":[47,117,122,151,258,347,390,393],"for":[48,76,267,401],"patients":[49,75,375],"receiving":[50],"specific":[51],"treatments.":[52,71],"METHODS:":[53],"The":[54],"was":[57,79],"randomised":[59,371],"controlled":[60,372],"trial":[61,373],"in":[62,374,385],"which":[63],"standard":[64],"drugs":[66,188],"were":[67,87,94,106,274],"compared":[68],"new":[70],"Arm":[72],"A":[73],"included":[74],"whom":[77,86],"carbamazepine":[78],"considered":[80],"first-line":[82],"treatment,":[83],"most":[84],"newly":[88],"diagnosed":[89],"focal":[91],"epilepsy.":[92],"Patients":[93],"randomly":[95],"assigned":[96],"receive":[98],"carbamazepine,":[99,262,351,356],"gabapentin,":[100],"lamotrigine,":[101],"oxcarbazepine,":[102],"or":[103,208,223,242,302,343],"topiramate.":[104],"Outcomes":[105],"time":[107,123,162,268,306],"failure":[110,150],"overall,":[111],"because":[112,118],"inadequate":[114],"seizure":[115,235,309],"control,":[116],"adverse":[120],"events,":[121],"12":[125,156,270],"months":[126,157,271,311,318],"seizures.":[130],"In":[131],"this":[132],"post-hoc":[133],"used":[136],"regression":[137],"multivariable":[138],"modelling":[139],"investigate":[141],"how":[142],"clinical":[143],"factors":[144,266,367],"affect":[145],"probability":[147,153],"achieving":[155],"remission.":[159],"FINDINGS:":[160],"For":[161],"failure,":[165],"identified":[167],"several":[168],"significant":[169],"risk":[170,388],"factors:":[171],"sex":[172,275],"(male":[173,276],"vs":[174,194,205,221,231,240,253,261,277,288,299,312,319,327,341,350,355],"female,":[175,278],"hazard":[176],"ratio":[177],"[HR]":[178],"0\u00b786,":[179],"95%":[180],"CI":[181],"0\u00b775-0\u00b799),":[182],"history":[184,282],"(taking":[185,283],"non-SANAD":[186,285],"[other":[189],"than":[190,202,296],"those":[191],"listed":[192],"above]":[193],"naive,":[196,290],"1\u00b727,":[197],"1\u00b705-1\u00b753),":[198],"age":[199,293],"(eg,":[200,216,237,294,337],"older":[201,295],"71":[203,297],"years":[204,207,298,301],"10":[206,300],"younger,":[209,303],"0\u00b768,":[210],"0\u00b751-0\u00b791),":[211],"total":[212,331],"number":[213,332],"four":[217,338],"11":[219,340],"two":[222,342],"fewer,":[224,344],"1\u00b708,":[225],"1\u00b705-1\u00b711),":[226],"electroencephalogram":[227],"results":[228],"(epileptiform":[229],"abnormality":[230],"normal,":[232],"1\u00b726,":[233],"1\u00b707-1\u00b750),":[234],"type":[236],"secondary":[238],"generalised":[239],"simple":[241],"complex":[243],"partial":[244],"only,":[245],"0\u00b778,":[246],"0\u00b766-0\u00b791),":[247],"site":[248],"onset":[250],"(not":[251],"localised":[252],"temporal":[254],"lobe,":[255],"1\u00b725,":[256],"1\u00b706-1\u00b747),":[257],"(lamotrigine":[260],"0\u00b776,":[263],"0\u00b761-0\u00b795).":[264],"Significant":[265],"1\u00b719,":[279],"1\u00b705-1\u00b735),":[280],"0\u00b764,":[291],"0\u00b752-0\u00b778),":[292],"1\u00b760,":[304],"1\u00b726-2\u00b703),":[305],"(60-239":[310],"\u22652":[313],"months,":[314,321],"1\u00b714,":[315],"1\u00b701-1\u00b729;":[316],">240":[317],"\u22642":[320],"1\u00b739,":[322],"1\u00b704-1\u00b786),":[323],"neurological":[324],"insult":[325],"(present":[326],"absent,":[328],"0\u00b775,":[329],"0\u00b761-0\u00b793),":[330],"before":[335],"randomisation":[336],"0\u00b787,":[345],"0\u00b785-0\u00b790),":[346],"(gabapentin":[349],"0\u00b771,":[352],"0\u00b759-0\u00b786;":[353],"topiramate":[354],"0\u00b781,":[357],"0\u00b768-0\u00b798).":[358],"INTERPRETATION:":[359],"We":[360],"present":[361],"thorough":[363],"investigation":[364],"large":[370],"starting":[376],"monotherapy.":[378],"If":[379],"validated,":[380],"our":[381],"could":[383],"aid":[384],"individual":[386],"patient":[387],"stratification":[389],"design":[392],"analysis":[394],"epilepsy":[396],"trials.":[397],"FUNDING:":[398],"National":[399],"Institute":[400],"Health":[402],"Research":[403],"(UK).":[404]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}